Bridgefront Capital’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-35,905
| Closed | -$165K | – | 350 |
|
|
2023
Q3 | $165K | Buy |
35,905
+13,314
| +59% | +$61.2K | 0.12% | 328 |
|
|
2023
Q2 | $146K | Sell |
22,591
-1,037
| -4% | -$6.7K | 0.08% | 405 |
|
|
2023
Q1 | $178K | Buy |
23,628
+9,858
| +72% | +$74.3K | 0.11% | 355 |
|
|
2022
Q4 | $139K | Buy |
+13,770
| New | +$139K | 0.1% | 318 |
|